The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver

Journal of Hepatology

Volumn 55, Issue 6, 2011, Pages 1409-1414

  Valenti, Luca ^a   Nobili, Valerio ^b   Al Serri, Ahmad ^c   Rametta, Raffaela ^a   Leathart, Julian B S ^c   Zappa, Marco A ^a   Dongiovanni, Paola ^a   Fracanzani, Anna L ^a   Alterio, Arianna ^b   Roviaro, Giancarlo ^a   Daly, Ann K ^c   Fargion, Silvia ^a   Day, Christopher P ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b Bambin Ges Hospital   (Italy)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Apolipoprotein C3; Dyslipidemia; Genetics; Insulin resistance; Liver fibrosis; Nonalcoholic fatty liver disease; Promoter polymorphism; Steatohepatitis

Indexed keywords

APOLIPOPROTEIN C3; MESSENGER RNA; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CAUCASIAN; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INSULIN RESISTANCE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ADOLESCENT; ADULT; APOLIPOPROTEIN C-III; BASE SEQUENCE; CASE-CONTROL STUDIES; CHILD; DNA PRIMERS; FATTY LIVER; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREAT BRITAIN; HUMANS; ITALY; LIPASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 81255198296     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.03.035     Document Type: Article

References (36)

1. J.D. Browning, L.S. Szczepaniak, R. Dobbins, P. Nuremberg, J.D. Horton, and J.C. Cohen Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
2. S. Bellentani, G. Saccoccio, F. Masutti, L.S. Croce, G. Brandi, and F. Sasso Prevalence of and risk factors for hepatic steatosis in Northern Italy Ann Intern Med 132 2000 112 117
3. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, and M. Lenzi Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850
4. M. Ekstedt, L.E. Franzen, U.L. Mathiesen, L. Thorelius, M. Holmqvist, and G. Bodemar Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
5. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, and P. Carucci Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
6. A. Gastaldelli, S.A. Harrison, R. Belfort-Aguilar, L.J. Hardies, B. Balas, and S. Schenker Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis Hepatology 50 2009 1087 1093
7. C.P. Day From fat to inflammation Gastroenterology 130 2006 207 210
8. G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, and R. Manini Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923
9. P. Dongiovanni, L. Valenti, R. Rametta, A.K. Daly, V. Nobili, and E. Mozzi Genetic variants regulating insulin receptor signaling are associated with the severity of liver damage in patients with nonalcoholic fatty liver disease Gut 59 2010 267 273
10. N.M. Wilfred de Alwis, and C.P. Day Genetics of alcoholic liver disease and nonalcoholic fatty liver disease Semin Liver Dis 27 2007 44 54
11. J.B. Schwimmer, M.A. Celedon, J.E. Lavine, R. Salem, N. Campbell, and N.J. Schork Heritability of nonalcoholic fatty liver disease Gastroenterology 136 2009 1585 1592
12. R. Guerrero, G.L. Vega, S.M. Grundy, and J.D. Browning Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology 49 2009 791 801
13. J. Makkonen, K.H. Pietilainen, A. Rissanen, J. Kaprio, and H. Yki-Jarvinen Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins J Hepatol 50 2009 1035 1042
14. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
15. L. Valenti, A. Al-Serri, A.K. Daly, E. Galmozzi, R. Rametta, and P. Dongiovanni Homozygosity for the PNPLA3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1209 1217
16. L. Valenti, A. Alisi, E. Galmozzi, A. Bartuli, B. Del Menico, and A. Alterio I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease Hepatology 52 2010 1274 1280
17. Y. Rotman, C. Koh, J.M. Zmuda, D.E. Kleiner, and T.J. Liang The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease Hepatology 52 2010 894 903
18. L. Valenti, E. Canavesi, E. Galmozzi, P. Dongiovanni, R. Rametta, and P. Maggioni Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease J Hepatol 53 2010 927 933
19. P. Dongiovanni, R. Rametta, A.L. Fracanzani, L. Benedan, V. Borroni, and P. Maggioni Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case-control study BMC Gastroenterol 10 2010 102
20. J. Altomonte, L. Cong, S. Harbaran, A. Richter, J. Xu, and M. Meseck Foxo1 mediates insulin action on apoC-III and triglyceride metabolism J Clin Invest 114 2004 1493 1503
21. K.F. Petersen, S. Dufour, A. Hariri, C. Nelson-Williams, J.N. Foo, and X.M. Zhang Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease N Engl J Med 362 2010 1082 1089
22. P. Mathurin, A. Hollebecque, L. Arnalsteen, D. Buob, E. Leteurtre, and R. Caiazzo Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease Gastroenterology 137 2009 532 540
23. S. Romeo, F. Sentinelli, S. Dash, G.S. Yeo, D.B. Savage, and F. Leonetti Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent Int J Obes (Lond) 34 2010 190 194
24. L. Valenti HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease Gastroenterology 138 2010 905 912
25. L. Valenti, A.L. Fracanzani, P. Dongiovanni, G. Santorelli, A. Branchi, and E. Taioli Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease Gastroenterology 122 2002 274 280
26. G. Bedogni, S. Bellentani, L. Miglioli, F. Masutti, M. Passalacqua, and A. Castiglione The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population BMC Gastroenterol 6 2006 33
27. L. Miele, G. Beale, G. Patman, V. Nobili, J. Leathart, and A. Grieco The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease Gastroenterology 135 2008 282 291 e281
28. R.S. Spielman, R.E. McGinnis, and W.J. Ewens Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am J Hum Genet 52 1993 506 516
29. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
30. A.K. Daly, B.P. King, and J.B. Leathart Genotyping for cytochrome P450 polymorphisms Methods Mol Biol 320 2006 193 207
31. S. Cheng, C. Pallaud, M.A. Grow, S.J. Scharf, H.A. Erlich, and W. Klitz A multilocus genotyping assay for cardiovascular disease Clin Chem Lab Med 36 1998 561 566
32. R.A. Hegele, P.W. Connelly, A.J. Hanley, F. Sun, S.B. Harris, and B. Zinman Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins Arterioscler Thromb Vasc Biol 17 1997 2753 2758
33. J. Kozlitina, E. Boerwinkle, J.C. Cohen, and H.H. Hobbs Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance Hepatology 53 2011 467 474
34. T.I. Pollin, C.M. Damcott, H. Shen, S.H. Ott, J. Shelton, and R.B. Horenstein A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection Science 322 2008 1702 1705
35. O. Olivieri, N. Martinelli, M. Sandri, A. Bassi, P. Guarini, and E. Trabetti Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and "insulin-resistant" T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction Clin Chem 51 2005 360 367
36. E.K. Speliotes, J.L. Butler, C.D. Palmer, B.F. Voight, and J.N. Hirschhorn PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease Hepatology 52 2010 904 912